MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1055/a-2888-9768

Медицинская библиотека · Thrombosis and haemostasis · 2026

Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes.

Lahu Doruntina, Simonetti Fiorenzo, Koka Elda, Mayer Katharina, Lahu Shqipdona, Schüpke Stefanie, Janisch Marion, Laugwitz Karl-Ludwig, Schunkert Heribert, Kastrati Adnan, Bernlochner Isabell

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Data on sex-specific pharmacodynamic differences between prasugrel and ticagrelor in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) are limited.

BACKGROUND

This study aims to evaluate sex-specific differences in platelet inhibition with prasugrel and ticagrelor in ACS patients undergoing PCI.

MATERIALS AND

METHODS

This prespecified ISAR-REACT (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment) 5 substudy included 598 P2Y12 inhibitor-naive patients (126 women, 472 men) undergoing PCI with one platelet function test within 24 hours after loading with prasugrel or ticagrelor. The primary endpoint was adenosine diphosphate (ADP)-induced platelet aggregation (PA) ≤24 hours post-loading. Ischemic events (death, myocardial infarction, or stroke) and major bleeding (Bleeding Academic Research Consortium [BARC] 3-5) were assessed at 12 months.

RESULTS

Baseline ADP-induced PA was higher in women. After loading, women had lower PA than men (median 92 vs. 122 aggregation units [AU] × min; p = 0.006). Multivariable analysis showed that male sex and ticagrelor were independently associated with higher PA, with a significant sex-by-treatment interaction (p = 0.031). Women had significantly lower PA than men with prasugrel (77 vs. 118 AU × min; p = 0.001), but similar PA with ticagrelor (136 vs. 138 AU × min; p = 0.787). Twelve-month ischemic outcomes were similar between sexes in both groups. Major bleeding was higher in women than men receiving prasugrel (13.6% vs. 5.6%; Hazard Ratio (HR) 2.61; p = 0.023), but similar with ticagrelor.

CONCLUSION

In patients with ACS undergoing PCI, women exhibited higher baseline platelet reactivity than men. After loading with the study drug, women showed stronger platelet inhibition than men with prasugrel, but not with ticagrelor. A significant interaction between sex and treatment effect on ADP-induced PA was observed.

Для цитирования: Lahu Doruntina, Simonetti Fiorenzo, Koka Elda, Mayer Katharina, Lahu Shqipdona, Schüpke Stefanie, Janisch Marion, Laugwitz Karl-Ludwig, Schunkert Heribert, Kastrati Adnan, Bernlochner Isabell. Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes.. Thrombosis and haemostasis. 2026. DOI: 10.1055/a-2888-9768.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.